Overview

Xolair Enhances Oral Desensitization in Peanut Allergic Patients

Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This is a pilot feasibility study, using Xolair pretreatment for oral peanut desensitization.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Lynda Schneider
Treatments:
Omalizumab